Concepedia

Prashanti Madhavapeddi

PM

Statistics

Publications

13

Citations

812

H-Index

13

Active since

2001

Affiliations

AstraZeneca (India)(Current)

AstraZeneca (United Kingdom)

AstraZeneca (United States)

AstraZeneca (Brazil)

AstraZeneca (South Korea)

Prashanti Madhavapeddi is an author at AstraZeneca (India) specializing in drug discovery, pharmacology, and enzyme inhibition.

Publications per year

2001–2016

13

Publications

13

Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious <i>in Vivo</i>

Pravin S. Shirude, Radha Krishan Shandil, C Sadler et al. · Journal of Medicinal Chemistry · 2013 · 162 citations

, , +14

Methyl-Thiazoles: A Novel Mode of Inhibition with the Potential to Develop Novel Inhibitors Targeting InhA in Mycobacterium tuberculosis

Pravin S. Shirude, Prashanti Madhavapeddi, Maruti Naik et al. · Journal of Medicinal Chemistry · 2013 · 101 citations · Full text

, , +17

4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity

Maruti Naik, Vaishali Humnabadkar, Subramanyam J. Tantry et al. · Journal of Medicinal Chemistry · 2014 · 94 citations · Full text

, , +16

Aminopyrazinamides: Novel and Specific GyrB Inhibitors that Kill Replicating and Nonreplicating <i>Mycobacterium tuberculosis</i>

Pravin S. Shirude, Prashanti Madhavapeddi, Julie A. Tucker et al. · ACS Chemical Biology · 2012 · 88 citations

, , +17

Thiazolopyridine Ureas as Novel Antitubercular Agents Acting through Inhibition of DNA Gyrase B

Manoj Kale, Anandkumar Raichurkar, Shahul Hameed P et al. · Journal of Medicinal Chemistry · 2013 · 66 citations · Full text

, , +15

1–5 of 13